Patent · US Expired

Iron dextran formulations

US5624668A · kind A · utility

57Cited by

21References

28Claims

0Family size

Assignee

Luitpold Pharmaceuticals, Inc. · US

Inventors

Richard P. Lawrence · Southold, US
Ralf Lange · Krefeld, DE
Chin-Chung Wu · Taipei, TW
Mary Jane Helenek · Brookville, US

Key dates

Filing date	Sep 29, 1995
Grant date	Apr 29, 1997
Priority date	—
Expiry date	Sep 29, 2015

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Ferric oxyhydroxide-dextran compositions for treating iron deficiency having ellipsoidal particles with a preferred molecular weight range of about 250,000 to 300,000 daltons.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.